Health ❯ Pharmaceuticals ❯ Weight Loss

GLP-1 Drugs

Wegovy Novo Nordisk Consumer Behavior Ozempic Social Impact Orforglipron Side Effects Serena Williams Ozempic and Wegovy Market Trends Mounjaro and Zepbound Appetite Suppressants Market Access Lobbying Wegovy and Ozempic Cost and Accessibility Retatrutide Obesity Treatment Consumer Impact

GLP-1 Weight-Loss Push Intensifies as Novo Leads Ads and Wegovy Pill Drives Telehealth Uptake

New disclosures show continued lobbying on pricing, Medicare coverage, and access despite public deals with the Trump administration.

Weight-Loss Pills Could Trim Airline Fuel Costs, Jefferies Says

Strive Compounding Sues Lilly and Novo, Alleging Antitrust Push to Block Compounded GLP-1s

Costco Adds $499 Ozempic and Wegovy Offer Across U.S. Pharmacies

Guidelines Tie Diet and Exercise to GLP-1 Drug Success as India Launches Treatments